Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hecht Olsen

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
European Journal of Endocrinology|February 14, 2016
Follow-up duration influences the relative importance of OGTT and optimal timing of glucose measurements for predicting future type 2 diabetesMette Lundgren Nielsen, Manan Pareek, Margrét Leósdóttir, et al.
The Lancet. Global Health|December 16, 2017
Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trialDinesh Neupane, Craig S McLachlan, Shiva Raj Mishra, et al.
Ugeskrift for Laeger|June 21, 2024
Louise Ladebo, Erlend Riksheim Thomassen, Mikkel Bryne, et al.
Blood Pressure|December 3, 2002
Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery in patients with longstanding hypertension. A LIFE substudyMichael Hecht Olsen, Kristian Wachtell, Kristine L Hermann, et al.
Blood Pressure|March 19, 2025
OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020Alaa Sharfo, Astrid Lahn Sørensen, Emil Eik Nielsen, et al.
Systematic Reviews|December 19, 2019
Adding exercise to usual care in patients with hypertension, type 2 diabetes mellitus and/or cardiovascular disease: a protocol for a systematic review with meta-analysis and trial sequential analysisAnupa Rijal, Emil Eik Nielsen, Bianca Hemmingsen, et al.
Diabetes & Vascular Disease Research|September 28, 2020
Coronary flow impairment in asymptomatic patients with early stage type-2 diabetes: Detection by FFR<sub>CT</sub>Monija Mrgan, Bjarne Linde Nørgaard, Damini Dey, et al.
Cardiology|May 10, 2022
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and ConsAnna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, et al.
American Heart Journal|September 14, 2002
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in HypertensionMichael Hecht Olsen, Kristian Wachtell, Kirstine L Hermann, et al.
Open Heart|December 1, 2020
Beneficial and harmful effects of sacubitril/valsartan in patients with heart failure: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysisEmil Eik Nielsen, Joshua Buron Feinberg, Fan-Long Bu, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
European Journal of Endocrinology|February 14, 2016
Follow-up duration influences the relative importance of OGTT and optimal timing of glucose measurements for predicting future type 2 diabetesMette Lundgren Nielsen, Manan Pareek, Margrét Leósdóttir, et al.
The Lancet. Global Health|December 16, 2017
Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trialDinesh Neupane, Craig S McLachlan, Shiva Raj Mishra, et al.
Ugeskrift for Laeger|June 21, 2024
Louise Ladebo, Erlend Riksheim Thomassen, Mikkel Bryne, et al.
Blood Pressure|December 3, 2002
Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery in patients with longstanding hypertension. A LIFE substudyMichael Hecht Olsen, Kristian Wachtell, Kristine L Hermann, et al.
Blood Pressure|March 19, 2025
OPTIHEART: determinants and prognostic importance of optimal medical treatment in patients with heart failure with reduced ejection fraction discharged from a heart failure clinic from 2018 to 2020Alaa Sharfo, Astrid Lahn Sørensen, Emil Eik Nielsen, et al.
Systematic Reviews|December 19, 2019
Adding exercise to usual care in patients with hypertension, type 2 diabetes mellitus and/or cardiovascular disease: a protocol for a systematic review with meta-analysis and trial sequential analysisAnupa Rijal, Emil Eik Nielsen, Bianca Hemmingsen, et al.
Diabetes & Vascular Disease Research|September 28, 2020
Coronary flow impairment in asymptomatic patients with early stage type-2 diabetes: Detection by FFR<sub>CT</sub>Monija Mrgan, Bjarne Linde Nørgaard, Damini Dey, et al.
Cardiology|May 10, 2022
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and ConsAnna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, et al.
American Heart Journal|September 14, 2002
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in HypertensionMichael Hecht Olsen, Kristian Wachtell, Kirstine L Hermann, et al.
Open Heart|December 1, 2020
Beneficial and harmful effects of sacubitril/valsartan in patients with heart failure: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysisEmil Eik Nielsen, Joshua Buron Feinberg, Fan-Long Bu, et al.
Pageof 13